NCT06148038View on ClinicalTrials.gov

CBD for Breast Cancer Primary Tumors

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

March 1, 2026

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2028

Conditions

Breast Cancer

Interventions

DRUG

CBD Oral

CBD Oral 350mg twice daily for 28 days

OTHER

Control

Placebo Control

All Listed Sponsors

lead

Medical University of South Carolina

OTHER